You are here

AdvaMedDx Priorities 2021

In 2020, the IVD industry rapidly mobilized to develop and radically scale-up manufacturing to meet the unprecedented demand for quality COVID-19 diagnostics and other critical tests. AdvaMed and AdvaMedDx have prioritized supporting MedTech’s mobilization to the pandemic to protect patients and public health through the development of and advocacy on a wide range of policy matters both administrative and legislative to foster innovation, expand access to testing and to bolster testing infrastructure and capability for future pandemic preparedness.

Read the priorities